Xinidamine

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 341439

CAS#: 50264-78-3

Description: Xinidamine is a biochemical.

Chemical Structure

img
Xinidamine
CAS# 50264-78-3
Instruction

Theoretical Analysis

MedKoo Cat#: 341439
Name: Xinidamine
CAS#: 50264-78-3
Chemical Formula: C17H16N2O2
Exact Mass: 280.12
Molecular Weight: 280.327
Elemental Analysis: C, 72.84; H, 5.75; N, 9.99; O, 11.41

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Xinidamine; BRN 0891979; Xinidamino; Xinidaminum.

IUPAC/Chemical Name: 1-(2,4-Dimethylbenzyl)-1H-indazole-3-carboxylic acid

InChi Key: WHWIXTDKNBCRAS-UHFFFAOYSA-N

InChi Code: InChI=1S/C17H16N2O2/c1-11-7-8-13(12(2)9-11)10-19-15-6-4-3-5-14(15)16(18-19)17(20)21/h3-9H,10H2,1-2H3,(H,20,21)

SMILES Code: O=C(C1=NN(CC2=CC=C(C)C=C2C)C3=C1C=CC=C3)O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 280.33 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Chen H, Chen F, Hu W, Gou S. Effective platinum(IV) prodrugs conjugated with lonidamine as a functional group working on the mitochondria. J Inorg Biochem. 2018 Mar;180:119-128. doi: 10.1016/j.jinorgbio.2017.11.017. Epub 2017 Nov 21. PubMed PMID: 29253663.

2: Cohen-Erez I, Rapaport H. Negatively charged polypeptide-peptide nanoparticles showing efficient drug delivery to the mitochondria. Colloids Surf B Biointerfaces. 2018 Feb 1;162:186-192. doi: 10.1016/j.colsurfb.2017.11.048. Epub 2017 Nov 22. PubMed PMID: 29190470.

3: Liu Y, Zhang X, Zhou M, Nan X, Chen X, Zhang X. Mitochondrial-Targeting Lonidamine-Doxorubicin Nanoparticles for Synergistic Chemotherapy to Conquer Drug Resistance. ACS Appl Mater Interfaces. 2017 Dec 20;9(50):43498-43507. doi: 10.1021/acsami.7b14577. Epub 2017 Dec 7. PubMed PMID: 29171954.

4: Albatany M, Li A, Meakin S, Bartha R. Dichloroacetate induced intracellular acidification in glioblastoma: in vivo detection using AACID-CEST MRI at 9.4 Tesla. J Neurooncol. 2018 Jan;136(2):255-262. doi: 10.1007/s11060-017-2664-9. Epub 2017 Nov 16. PubMed PMID: 29143921.

5: Singh A, Sen E. Reciprocal role of SIRT6 and Hexokinase 2 in the regulation of autophagy driven monocyte differentiation. Exp Cell Res. 2017 Nov 15;360(2):365-374. doi: 10.1016/j.yexcr.2017.09.028. Epub 2017 Sep 19. PubMed PMID: 28935467.

6: Ruttala HB, Chitrapriya N, Kaliraj K, Ramasamy T, Shin WH, Jeong JH, Kim JR, Ku SK, Choi HG, Yong CS, Kim JO. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy. Acta Biomater. 2017 Nov;63:135-149. doi: 10.1016/j.actbio.2017.09.002. Epub 2017 Sep 7. PubMed PMID: 28890258.

7: Yue C, Yang Y, Song J, Alfranca G, Zhang C, Zhang Q, Yin T, Pan F, de la Fuente JM, Cui D. Mitochondria-targeting near-infrared light-triggered thermosensitive liposomes for localized photothermal and photodynamic ablation of tumors combined with chemotherapy. Nanoscale. 2017 Aug 10;9(31):11103-11118. doi: 10.1039/c7nr02193c. PubMed PMID: 28741634.

8: Nath K, Nelson DS, Roman J, Putt ME, Lee SC, Leeper DB, Glickson JD. Effect of Lonidamine on Systemic Therapy of DB-1 Human Melanoma Xenografts with Temozolomide. Anticancer Res. 2017 Jul;37(7):3413-3421. PubMed PMID: 28668829.

9: Cervantes-Madrid D, Dominguez-Gomez G, Gonzalez-Fierro A, Perez-Cardenas E, Taja-Chayeb L, Trejo-Becerril C, Duenas-Gonzalez A. Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6-diazo-5-oxo-L-norleucine and orlistat in colon cancer. Oncol Lett. 2017 Mar;13(3):1905-1910. doi: 10.3892/ol.2017.5615. Epub 2017 Jan 18. PubMed PMID: 28454342; PubMed Central PMCID: PMC5403504.

10: Mruk DD, Bonanomi M, Silvestrini B. Lonidamine-ethyl ester-mediated remodelling of the Sertoli cell cytoskeleton induces phosphorylation of plakoglobin and promotes its interaction with α-catenin at the blood-testis barrier. Reprod Fertil Dev. 2017 Apr;29(5):998-1011. doi: 10.1071/RD15378. PubMed PMID: 28442050.

11: Kaznatcheev A, Vander Velde R, Scott JG, Basanta D. Cancer treatment scheduling and dynamic heterogeneity in social dilemmas of tumour acidity and vasculature. Br J Cancer. 2017 Mar 14;116(6):785-792. doi: 10.1038/bjc.2017.5. Epub 2017 Feb 9. PubMed PMID: 28183139; PubMed Central PMCID: PMC5355932.

12: Tan W, Zhong Z, Wang S, Liu H, Yu H, Tan R, Hu X, Pan T, Wang Y. The Typical Metabolic Modifiers Conferring Improvement in Cancer Resistance. Curr Med Chem. 2017 Nov 17;24(34):3698-3710. doi: 10.2174/0929867324666170203121449. Review. PubMed PMID: 28164760.

13: Thamrongwaranggoon U, Seubwai W, Phoomak C, Sangkhamanon S, Cha'on U, Boonmars T, Wongkham S. Targeting hexokinase II as a possible therapy for cholangiocarcinoma. Biochem Biophys Res Commun. 2017 Mar 4;484(2):409-415. doi: 10.1016/j.bbrc.2017.01.139. Epub 2017 Jan 25. PubMed PMID: 28131825.

14: Golding JP, Kemp-Symonds JG, Dobson JM. Glycolysis inhibition improves photodynamic therapy response rates for equine sarcoids. Vet Comp Oncol. 2017 Dec;15(4):1543-1552. doi: 10.1111/vco.12299. Epub 2017 Jan 27. PubMed PMID: 28127949.

15: Reyes R, Wani NA, Ghoshal K, Jacob ST, Motiwala T. Sorafenib and 2-Deoxyglucose Synergistically Inhibit Proliferation of Both Sorafenib-Sensitive and -Resistant HCC Cells by Inhibiting ATP Production. Gene Expr. 2017 Feb 10;17(2):129-140. doi: 10.3727/105221616X693855. Epub 2016 Nov 16. PubMed PMID: 27938509; PubMed Central PMCID: PMC5296238.

16: Nath K, Guo L, Nancolas B, Nelson DS, Shestov AA, Lee SC, Roman J, Zhou R, Leeper DB, Halestrap AP, Blair IA, Glickson JD. Mechanism of antineoplastic activity of lonidamine. Biochim Biophys Acta. 2016 Dec;1866(2):151-162. doi: 10.1016/j.bbcan.2016.08.001. Epub 2016 Aug 4. Review. PubMed PMID: 27497601; PubMed Central PMCID: PMC5138080.

17: Marathe K, McVicar N, Li A, Bellyou M, Meakin S, Bartha R. Topiramate induces acute intracellular acidification in glioblastoma. J Neurooncol. 2016 Dec;130(3):465-472. Epub 2016 Sep 9. PubMed PMID: 27613534.

18: de Blas E, Estañ MC, Del Carmen Gómez de Frutos M, Ramos J, Del Carmen Boyano-Adánez M, Aller P. Selected polyphenols potentiate the apoptotic efficacy of glycolytic inhibitors in human acute myeloid leukemia cell lines. Regulation by protein kinase activities. Cancer Cell Int. 2016 Sep 7;16(1):70. doi: 10.1186/s12935-016-0345-y. eCollection 2016. PubMed PMID: 27610044; PubMed Central PMCID: PMC5015235.

19: Xia W, Geng K. A sirtuin activator and an anti-inflammatory molecule-multifaceted roles of adjudin and its potential applications for aging-related diseases. Semin Cell Dev Biol. 2016 Nov;59:71-78. doi: 10.1016/j.semcdb.2016.07.020. Epub 2016 Jul 20. Review. PubMed PMID: 27450234.

20: Nath K, Nelson DS, Putt ME, Leeper DB, Garman B, Nathanson KL, Glickson JD. Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice. PLoS One. 2016 Jun 10;11(6):e0157125. doi: 10.1371/journal.pone.0157125. eCollection 2016. PubMed PMID: 27285585; PubMed Central PMCID: PMC4902256.